These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 16814762

  • 1. A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.
    Ndrepepa G, Kastrati A, Braun S, Koch W, Kölling K, Mehilli J, Schömig A.
    Clin Chim Acta; 2006 Nov; 373(1-2):70-6. PubMed ID: 16814762
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome.
    van Oijen MG, Claessen BE, Clappers N, van Schaik A, Laheij RJ, Jansen JB, Peters WH, Verheugt FW.
    Am J Cardiol; 2008 Jul 15; 102(2):135-9. PubMed ID: 18602509
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease.
    Stefanescu A, Braun S, Ndrepepa G, Koppara T, Pavaci H, Mehilli J, Schömig A, Kastrati A.
    Am Heart J; 2008 Feb 15; 155(2):356-60. PubMed ID: 18215608
    [Abstract] [Full Text] [Related]

  • 4. Plasma homocysteine levels and mortality in patients with coronary artery disease.
    Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE.
    N Engl J Med; 1997 Jul 24; 337(4):230-6. PubMed ID: 9227928
    [Abstract] [Full Text] [Related]

  • 5. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
    Muhlestein JB, Anderson JL, Horne BD, Lavasani F, Allen Maycock CA, Bair TL, Pearson RR, Carlquist JF, Intermountain Heart Collaborative Study Group.
    Am Heart J; 2003 Aug 24; 146(2):351-8. PubMed ID: 12891207
    [Abstract] [Full Text] [Related]

  • 6. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
    Angiolillo DJ, Bernardo E, Sabaté M, Jimenez-Quevedo P, Costa MA, Palazuelos J, Hernández-Antolin R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Guzman LA, Bass TA, Macaya C, Fernandez-Ortiz A.
    J Am Coll Cardiol; 2007 Oct 16; 50(16):1541-7. PubMed ID: 17936152
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease.
    Ndrepepa G, Braun S, King L, Cassese S, Tada T, Fusaro M, Hadamitzky M, Haase HU, Schömig A, Kastrati A.
    Clin Sci (Lond); 2013 Feb 16; 124(4):259-68. PubMed ID: 22974091
    [Abstract] [Full Text] [Related]

  • 8. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V, Winkler K, Drechsler C, Lilienthal J, März W, Wanner C, German Diabetes and Dialysis Study Investigators.
    Am J Kidney Dis; 2009 Nov 16; 54(5):902-11. PubMed ID: 19781835
    [Abstract] [Full Text] [Related]

  • 9. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors.
    Gazzaruso C, Solerte SB, Pujia A, Coppola A, Vezzoli M, Salvucci F, Valenti C, Giustina A, Garzaniti A.
    J Am Coll Cardiol; 2008 May 27; 51(21):2040-4. PubMed ID: 18498958
    [Abstract] [Full Text] [Related]

  • 10. Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease.
    Mager A, Orvin K, Koren-Morag N, Lev IE, Assali A, Kornowski R, Shohat M, Battler A, Hasdai D.
    Am J Cardiol; 2009 Sep 15; 104(6):745-9. PubMed ID: 19733705
    [Abstract] [Full Text] [Related]

  • 11. Homocysteine and outcome in young patients with acute coronary syndromes.
    Martín-Herrero F, Martín-Moreiras J, Pabón P, Sánchez PL, Moríñigo-Muñoz JL, Jimenez-Candil J, Cruz-González I, Alberca I, González-Porras JR, Martín-Luengo C.
    Int J Cardiol; 2007 May 31; 118(2):183-8. PubMed ID: 17023077
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH, Lu TM, Wu TC, Lin FY, Chen YH, Chen JW, Lin SJ.
    Coron Artery Dis; 2008 May 31; 19(3):187-93. PubMed ID: 18418236
    [Abstract] [Full Text] [Related]

  • 13. Kidney disease as a predictor of mortality in chronic spinal cord injury.
    Greenwell MW, Mangold TM, Tolley EA, Wall BM.
    Am J Kidney Dis; 2007 Mar 31; 49(3):383-93. PubMed ID: 17336699
    [Abstract] [Full Text] [Related]

  • 14. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J, Kropf S, Luley C, Dierkes J.
    Am J Kidney Dis; 2009 Sep 31; 54(3):478-89. PubMed ID: 19359080
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E, PEACE Investigators.
    Circulation; 2007 Mar 27; 115(12):1528-36. PubMed ID: 17372173
    [Abstract] [Full Text] [Related]

  • 16. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C, Sudre A, Lemesle G, Maréchaux S, Broucqsault D, Hennache B, Bauters C, Lablanche JM.
    Cardiovasc Revasc Med; 2009 Mar 27; 10(3):144-50. PubMed ID: 19595394
    [Abstract] [Full Text] [Related]

  • 17. Routine use of bilateral skeletonized internal thoracic artery grafting: long-term results.
    Pevni D, Uretzky G, Mohr A, Braunstein R, Kramer A, Paz Y, Shapira I, Mohr R.
    Circulation; 2008 Aug 12; 118(7):705-12. PubMed ID: 18663087
    [Abstract] [Full Text] [Related]

  • 18. The impact of left ventricular hypertrophy on early and long-term survival after coronary artery bypass grafting.
    Toumpoulis IK, Chamogeorgakis TP, Angouras DC, Swistel DG, Anagnostopoulos CE, Rokkas CK.
    Int J Cardiol; 2009 Jun 12; 135(1):36-42. PubMed ID: 18579225
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of self-reported leisure-time physical activity to predict long-term survival in patients with coronary heart disease.
    Apullan FJ, Bourassa MG, Tardif JC, Fortier A, Gayda M, Nigam A.
    Am J Cardiol; 2008 Aug 15; 102(4):375-9. PubMed ID: 18678290
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of troponin T and homocysteine in patients with end-stage renal disease.
    Sahinarslan A, Güz G, Okyay K, Mutluay R, Yalçin R, Bali M, Sindel S, Cengel A.
    Turk Kardiyol Dern Ars; 2008 Sep 15; 36(6):382-7. PubMed ID: 19155641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.